ARTICLE | Clinical News
Anti-CD19 chimeric antigen receptor: Updated Phase I data
June 20, 2016 7:00 AM UTC
Data from 22 patients with DLBCL, follicular lymphoma or mantle cell lymphoma (MCL) in an open-label, U.S. Phase I trial showed that a single infusion of anti- CD19 CAR T cells given 2 days after comp...